PTGX

NASDAQStock$110.33+0.29 (+0.26%)
Mkt Cap 7.1BP/E Div Yield Beta 1.83Vol 310.3K
52W$49.70
$109.79

ETFs That Hold PTGX (Protagonist Therapeutics, Inc.)

1M

+7.44%

3M

+13.47%

6M

+19.93%

YTD

+25.92%

1Y

+100.84%

3Y

+282.78%

5Y

+187.76%

ETFs That Hold PTGX

Protagonist Therapeutics, Inc. is held by 127 ETFs. The largest position by market value is in IJR (iShares Core S&P Small-Cap ETF).

ETFFund NameWeight
EAORiShares ESG Aware 60/40 Balanced Allocation ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.01%
ITDBiShares LifePath Target Date 2030 ETF0.00%
MMTMState Street SPDR S&P 1500 Momentum Tilt ETF0.00%
IRTRiShares LifePath Retirement ETF0.00%
EAOMiShares ESG Aware 40/60 Moderate Allocation ETF0.00%
EAOKiShares ESG Aware 30/70 Conservative Allocation ETF0.00%

Excludes leveraged and inverse ETFs.

PreviousPage 7 of 7

Frequently Asked Questions

How many ETFs hold PTGX?
Protagonist Therapeutics, Inc. (PTGX) is held by 127 ETFs (excluding leveraged and inverse funds). The largest position by market value is in IJR (iShares Core S&P Small-Cap ETF).
What is the largest ETF that holds PTGX?
By fund size, IJR (iShares Core S&P Small-Cap ETF) with $107.38B in AUM holds 0.36% of its portfolio in PTGX, representing $370.9M in market value.
What percentage of NBDS is PTGX?
PTGX makes up 3.27% of NBDS (Neuberger Berman Disrupters ETF), making it one of the largest positions in that fund.
Is PTGX in the S&P 500?
PTGX is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.